What is Lasa Supergenerics share price return in the past 10 years?

Data is not available for this company

Lasa Supergenerics Ltd - Stock Valuation and Financial Performance

Name: Lasa Supergenerics
Brand: Lasa Supergenerics

BSE: 540702 | NSE: LASA | Pharmaceuticals & Drugs | Small Cap

Place order

Lasa Supergenerics Share Price

₹17.20 -0.70 -3.91%
as on 25-Apr'25 16:59

DeciZen - make an informed investing decision on Lasa Supergenerics

Based on:

Data

M-Cap below 100cr DeciZen not available

asa Supergenerics stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

86.2 Cr.

52-wk low:

16.5

52-wk high:

33.5

Related Stocks

Is Lasa Supergenerics Ltd an attractive stock to invest in?

1. Is Lasa Supergenerics Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Lasa Supergenerics Ltd is a below average quality company.

2. Is Lasa Supergenerics Ltd undervalued or overvalued?

The key valuation ratios of Lasa Supergenerics Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Lasa Supergenerics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Lasa Supergenerics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Lasa Supergenerics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	0%	0%	14.5%	12.8%	-3.7%	6.8%	17.1%	-3.4%	-23.9%	-13.2%	-
Value Creation Index ⓘ	NA	NA	0.0	-0.1	-1.3	-0.5	0.2	-1.2	-2.7	-2.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	199	244	170	167	202	137	130	104	126
Sales YoY Gr.	-	NA	NA	22.5%	-30.4%	-1.4%	21%	-32.2%	-5.5%	-19.5%	-
Adj EPS ⓘ	0	0	501.5	5.4	-5.2	1	5.6	0.1	-4.8	-3.1	-3.2
YoY Gr.	-	NA	NA	-98.9%	-196.7%	NA	475.3%	-97.9%	-4091.7%	NA	-
BVPS (₹) ⓘ	0	-60.2	10,983.3	51.3	46.1	34.8	39.1	31.5	23.6	19.3	19.2
Adj Net Profit ⓘ	0	0	2.5	12.3	-11.9	4	22.7	0.6	-24	-15.6	-16
Cash Flow from Ops. ⓘ	0	-0.4	-3	40.4	40.7	13.6	41.3	9.2	-17.3	2.1	-
Debt/CF from Ops. ⓘ	0	-1	-38.6	2.6	2.1	3.6	0.5	2.2	-1.3	10.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-9.3%	-19.8%	-19.5%
Adj EPS ⓘ	NA	NA	-182.3%	NA
BVPSⓘ	NA	-16%	-21%	-18.3%
Share Price	-	-14%	-33.3%	-32.5%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	0	6.6	12.8	-10.7	3.2	15.1	0.4	-17.4	-14.5	-16.4
Op. Profit Mgn % ⓘ	0	23	16.9	6.7	18.2	23.3	12.3	-3.6	2.2	-0.5
Net Profit Mgn % ⓘ	0	1.3	5.1	-7	2.4	11.2	0.5	-18.5	-14.9	-12.5
Debt to Equity ⓘ	-1.2	2.1	0.9	0.8	0.3	0.1	0.1	0.2	0.2	-
Working Cap Days ⓘ	0	66	138	206	169	118	147	123	130	60
Cash Conv. Cycle ⓘ	0	27	53	39	0	18	41	33	29	-16

Recent Performance Summary

Sales growth is good in last 4 quarters at 12.94%

Return on Equity is Poor

Sales growth has been subdued in last 3 years -19.81%

Latest Financials - Lasa Supergenerics Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-3.2	-
TTM Sales (₹ Cr.)	126	-
BVPS (₹.) ⓘ	19.2	-
Reserves (₹ Cr.) ⓘ	46	-
P/BV ⓘ	0.90	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	16.52 / 33.49
All Time Low / High (₹)	9.48 / 214.90
Market Cap (₹ Cr.)	86.2
Equity (₹ Cr.)	50.1
Face Value (₹)	10
Industry PE ⓘ	39.3

Quarterly Results

Standalone Basis

Consolidated Basis

	Mar'24	YoY Gr. Rt. %	Jun'24	YoY Gr. Rt. %	Sep'24	YoY Gr. Rt. %	Dec'24	YoY Gr. Rt. %
Sales (₹ Cr.)ⓘ	95.6	31.1	88	27.4	91.4	15.1	86.8	2.4
Adj EPS (₹) ⓘ	17.6	27.2	12.7	0.3	16.3	-8.4	1.3	-91.2
Op. Profit Mgn % ⓘ	13.17	-141 bps	7.18	-382 bps	11.62	-491 bps	4.09	-882 bps
Net Profit Mgn % ⓘ	11.35	-34 bps	8.89	-240 bps	10.99	-282 bps	0.90	-959 bps

Management X-Ray of Lasa Supergenerics:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

31.19

20.66

20.71

20.66

* Pledged shares as % of Promoter's holding (%)

Valuation of Lasa Supergenerics

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

No data found!

Key Ratios of Lasa Supergenerics

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Peer Comparison

Company Name	CMP(₹)	Change ₹(%)	Market Cap	Net Sales (₹ Cr.)	Latest EPS (₹)	Net Profit Margin %	Latest P/E	Latest P/BV
Alembic Pharma	875.5	-6 (-0.7%)	Small Cap	6,229	30.8	9.6	28.7	3.5
Laurus Labs	625.4	-21.8 (-3.4%)	Small Cap	5,041	6.6	3.1	97.4	8.3
Piramal Pharma	216	-3.9 (-1.8%)	Small Cap	4,390	5.2	8.4	42.4	4.1
Ajanta Pharma	2,677.2	-108.9 (-3.9%)	Small Cap	4,209	71.9	19	38.8	8.9
Gland Pharma	1,451.4	-14.2 (-1%)	Small Cap	4,167	68.1	24.8	21.5	2.6
Natco Pharma	889.7	-14 (-1.6%)	Small Cap	3,999	104.1	34.5	8.7	2.2
Granules India	452.2	-23.6 (-5%)	Small Cap	3,755	13.3	11.7	35.8	3.5
Emcure Pharma	1,027.8	-47.9 (-4.5%)	Small Cap	3,498	8.5	4.4	126.7	7.1
JB Chem & Pharma	1,576.1	-33.8 (-2.1%)	Small Cap	3,299	40.4	16.1	39.9	7.6
Wockhardt	1,396.4	-70.7 (-4.8%)	Small Cap	2,798	-11.8	-15.3	-	5.4

Shows rows:

Prev 1 2 3 4 5 Next

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	0	198.75	243.53	169.57	167.26	202.38	137.13	129.57	104.34
Operating Expenses ⓘ	0	153.23	202.26	158.52	137.29	155.17	121.11	136.17	102.11
Manufacturing Costs	0	9.56	13.92	12.68	15.75	17.51	12.40	13.93	15.33
Material Costs	0	130.89	171.51	127.95	94.65	112.35	91.29	106.11	75.22
Employee Cost	0	9.55	10.27	11.74	13.42	14.01	7.15	6.35	5.37
Other Costs ⓘ	0	3.23	6.56	6.16	13.47	11.30	10.27	9.77	6.20
Operating Profit ⓘ	0	45.52	41.26	11.05	29.97	47.21	16.02	-6.60	2.22
Operating Profit Margin (%)	-	22.9%	16.9%	6.5%	17.9%	23.3%	11.7%	-5.1%	2.1%
Other Income ⓘ	0	2.17	3.49	0.54	0.23	0.18	0.28	1.84	0.10
Interest ⓘ	0	11.68	11.35	8.38	8.12	2.06	0.06	4.19	1.99
Depreciation ⓘ	0	7.69	18.17	19.31	17.34	15.82	14.51	13.42	10.67
Exceptional Items ⓘ	0	-26.19	0	0	0	0	-7.86	-19.90	-8.77
Profit Before Tax ⓘ	0	2.14	15.23	-16.10	4.74	29.49	-6.14	-42.27	-19.11
Tax ⓘ	0	-0.22	2.89	-4.07	1.11	6.71	-0.81	-3.64	2.62
Profit After Tax	0	2.36	12.34	-12.03	3.63	22.78	-5.33	-38.62	-21.73
PAT Margin (%)	-	1.2%	5.1%	-7.1%	2.2%	11.3%	-3.9%	-29.8%	-20.8%
Adjusted EPS (₹)	0.0	472.5	5.4	-5.3	0.9	5.6	-1.1	-7.7	-4.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	4%	-23%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	0.05	54.92	117.34	105.30	141.47	158.92	157.88	118.29	96.68
Share Capital ⓘ	0.05	0.05	22.86	22.86	40.67	40.67	50.10	50.10	50.10
Reserves ⓘ	0	54.87	94.48	82.43	100.79	118.24	107.78	68.18	46.58
Minority Interest	0	0	0	0	0	0	0	0	0
Debt	0.35	103.87	90.10	68.73	34.48	0	0	0	0
Long Term Debt	0.35	80.68	60.27	45.72	14.14	0	0	0	0
Short Term Debt	0	23.19	29.83	23	20.34	0	0	0	0
Trade Payables	0	25.38	47.94	59.67	33.73	12.72	16.91	9.43	14.05
Others Liabilities ⓘ	0	44.08	31.40	21.78	19.14	36.22	34.38	36.14	40.14
Total Liabilities ⓘ	0.40	228.25	286.78	255.47	228.81	207.86	209.17	163.85	150.87
Fixed Assets
Gross Block	0	131.61	200.58	211.87	219.54	226.12	233.77	228.70	230.18
Accumulated Depreciation	0	12.78	30.94	50.17	67.35	83.17	96.49	109.74	120.42
Net Fixed Assetsⓘ	0	118.83	169.64	161.69	152.19	142.95	137.28	118.96	109.76
CWIP ⓘ	0	29.51	7.24	7.21	0	0	4.58	4.64	2.51
Investmentsⓘ	0	0	0	0	0	0	0.38	0.39	0
Inventories	0	33.46	42.23	31.60	26.30	17.26	11.50	13.90	19.04
Trade Receivables	0	34.97	42.15	28.88	20.65	14.77	18.56	2.48	3.59
Cash Equivalents	0.05	1.16	2.63	2.69	6.06	4.40	17.22	2.39	1.50
Others Assetsⓘ	0.35	10.31	22.88	23.41	23.61	28.48	19.66	21.09	14.47
Total Assets ⓘ	0.40	228.25	286.78	255.47	228.81	207.86	209.17	163.85	150.87

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	-0.35	-3	40.35	40.66	13.62	41.31	9.21	-17.30	2.14
PBT ⓘ	0	2.14	15.23	-16.10	4.74	29.49	1.72	-22.37	-19.11
Adjustment ⓘ	0	17.33	26.07	27.20	25.27	17.75	6.50	-4.07	8.42
Changes in Working Capital ⓘ	-0.35	-22.14	1.34	33.11	-16.01	-5.93	3.59	9.18	12.83
Tax Paid ⓘ	0	-0.33	-2.30	-3.54	-0.37	0	-2.59	-0.04	0
Cash Flow From Investing Activity ⓘ	0	0.38	-44.41	-7.34	-1.63	-3.60	-2.91	11.19	-0.40
Capex	0	-1.69	-46.71	-11.33	-0.63	-6.59	2.58	4.83	0.66
Net Investments	0	0	-1.12	-0.13	-1.23	2.93	-5.59	4.56	1.09
Others ⓘ	0	2.07	3.41	4.12	0.23	0.06	0.10	1.80	-2.15
Cash Flow From Financing Activityⓘ	0.40	0.05	4.41	-33.40	-9.85	-36.44	-0.04	-4.16	-1.93
Net Proceeds from Shares ⓘ	0.05	0	29.52	0	32.50	0	0	0	0
Net Proceeds from Borrowing ⓘ	0.35	6.18	-20.41	-14.55	-31.58	-14.14	0	0	0
Interest Paid ⓘ	0	-11.68	-11.34	-12.02	-8.10	-1.96	-0.04	-4.16	-1.93
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0
Others ⓘ	0	5.55	6.65	-6.83	-2.67	-20.34	0	0	0
Net Cash Flow ⓘ	0.05	-2.57	0.35	-0.08	2.15	1.27	6.26	-10.27	-0.19

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	0	8.65	14.33	-10.81	2.94	15.17	-3.37	-27.97	-20.22
ROCE (%)	0	14.45	12.8	-3.73	6.77	17.14	-3.41	-23.94	-13.23
Asset Turnover Ratio	0	1.91	0.95	0.63	0.69	0.93	0.66	0.69	0.66
PAT to CFO Conversion(x)	N/A	-1.27	3.27	N/A	3.75	1.81	N/A	N/A	N/A
Working Capital Days
Receivable Days	0	58	57	76	54	32	44	30	11
Inventory Days	0	56	56	79	63	39	38	36	58
Payable Days	0	71	78	153	180	75	59	45	57

Lasa Supergenerics Ltd Stock News

View All News

Lasa Supergenerics Ltd FAQs

What is the share price of Lasa Supergenerics?

Company share prices are keep on changing according to the market conditions. The closing price of Lasa Supergenerics on 25-Apr-2025 16:59 is ₹17.20.

What is the market cap of Lasa Supergenerics?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 25-Apr-2025 16:59 the market cap of Lasa Supergenerics stood at ₹86.17.